Showing results (41-50 of 961) with videos related to
Sort By:
Pageof 97
Ejhaem|July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone diseaseHirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.Ejhaem|July 18, 2022
Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapiesRyosuke Naka, Hitomi Kaneko, Osamu Nagata, et al.Ejhaem|July 18, 2022
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomesAbraham Avigdor, Fabrizio Trinchese, Francois Gavini, et al.Ejhaem|July 18, 2022
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignanciesJoan How, Siyang Ren, Jennifer Lombardi-Story, et al.Ejhaem|July 18, 2022
A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategiesJeffrey P Sharman, Juliana M L Biondo, Michelle Boyer, et al.Ejhaem|July 18, 2022
Impact of aspirin on bleeding and blood product usage in off-pump and on-pump coronary artery bypass graft surgeryChristopher Little, Zain Odho, Richard Szydlo, et al.Ejhaem|July 18, 2022
Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countriesMohammadali Jahangirpour, Amirali Vahedi, Hamed Baghdadi, et al.Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.Ejhaem|July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphomaClara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.Ejhaem|July 18, 2022
Ruxolitinib is effective in the treatment of a patient with refractory T-ALLSonia Jaramillo, Hannah Hennemann, Peter Horak, et al.Pageof 97